We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Global Medical Robotics Market to Reach USD 20 Billion by 2022

By HospiMedica International staff writers
Posted on 20 Sep 2017
The global medical robotics market is expected to grow at a CAGR of 21.6%from USD 6.36 billion in 2016 to USD 20.56 billion by 2022, driven by the enhancement of automation technologies, rising incidence of disabilities in human beings and growing baby boomer population, that impede their day-to-day physical motions.

These are the latest findings of Research and Markets (Dublin, Ireland), a global market research company.
Medical robots are used by surgeons to gain greater access to areas under operation using more detailed and less invasive methods. They are present in most telemanipulators, which use the surgeon's actions on one side and to control the "effector" on the other side.

Currently, the demand for medical robots is driven by the rapidly growing demand for precise and efficient minimally invasive surgeries, although the high cost of surgery, negative publicity, and wariness among people continue to pose a challenge to the market growth. The neurology segment is expected to register the fastest growth in the medical robots market during the forecast period, driven by the advent of newer applications in neurosurgery and the growing popularity of robotic neurosurgery.

In 2016, North America held the highest share of the global medical robotics market, due to the high adoption rate of medical robots in the region and the government's strong focus on medical robots to improve the quality of healthcare. The medical robotic systems market in Asia Pacific is expected to grow at the fastest rate during the forecast period due to the availability of untapped market opportunities.

Related Links:
Research and Markets


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology
New
Cylindrical Water Scanning System
SunSCAN 3D

Latest Business News

Expanded Collaboration to Transform OR Technology Through AI and Automation

Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business

Boston Scientific Acquires Medical Device Company SoniVie